Expression of human immunodeficiency virus (HIV) reverse transcr

Details Expression of human immunodeficiency virus (HIV) reverse transcr Expression of human immunodeficiency virus (HIV) reverse transcr

1988-12-28

1993-04-13

Schwartz, Richard A.

Chemistry: molecular biology and microbiology

Micro-organism, per se ; compositions thereof; proces of...

Bacteria or actinomycetales; media therefor

435 691, 435194, 435236, 4353201, 935 29, 935 38, 935 73, C12N 121, C12N 912, C12N 1510

Patent

active

052022595

ABSTRACT:
This invention provides a plasmid identified as pHRTRX2 and deposited in E. coli HB101 under ATCC Accession No. 67828. The invention also provides for a polypeptide having HIV reverse transcriptase activity and for a method by which the polypeptide can be prepared which comprises growing a host cell comprising the plasmid pHRTRX2 under suitable conditions permitting production of the polypeptide and recovering the resulting polypeptide.

REFERENCES:
patent: 4387162 (1983-06-01), Aigle et al.
patent: 4487835 (1984-12-01), Uhlin et al.
patent: 4663290 (1987-05-01), Weis et al.
Barr, P. J., et al., Bio/Technology, vol. 5, pp. 486-489 (1987).
Chandra, P., et al., Cancer-Research, vol. 45, pp. 4677s-4684s (1985).
Chang, N. T., et al., Science, vol. 228, pp. 93-96 (1985).
de Clercq, E. D., Cancer Letters, vol. 8, pp. 9-22 (1979).
di Marzo Veronese, F., et al., Science, vol. 231, pp. 1289-1291 (1986).
Farmerie, W. G., et al., Science, vol. 236, pp. 305-308 (1987).
Goff, S., et al., J. Virology, vol. 38, pp. 239-248 (1981).
Hansen, J., et al., J. Biol. Chem., vol. 262, pp. 12393-12396 (1987).
Hizi, A., et al., Proc. Natl. Acad. Sci. USA, vol. 85, pp. 1218-1222 (1988).
Hoffman, A. D., et al., Virology, vol. 147, pp. 326-335 (1985).
Johnson, M. S., et al., Proc. Natl. Acad. Sci. USA, vol. 83, pp. 7648-7652 (1986).
Larder, B., et al., EMBO Journal, vol. 6, pp. 3133-3137 (1987).
Larder, B. A., et al., Nature, vol. 327, pp. 716-717 (1987).
Lightfoote, M. M., et al., J. Virology, vol. 60, pp. 771-775 (1986).
Mitsuya, H., et al., Science, vol. 226, pp. 172-174 (1984).
Muesing, M. A., et al., Nature, vol. 313, pp. 450-458 (1985).
Ratner, L., et al., Nature, vol. 313, pp. 277-284 (1985).
Rey, M. A., et al., Biochem. and Biophysical Research Communications, vol. 121, pp. 126-133 (1984).
Roth, M. J., et al., J. Biol. Chem., vol. 260, pp. 9326-9335 (1985).
Spindler, K. R., et al., J. Virology, vol. 49, pp. 132-141 (1984).
Tacon, W., et al., Molec. gen. Genet., vol. 177, pp. 427-438 (1980).
Tanese, N., et al., Proc. Natl. Acad. Sci. U.S.A., vol. 82, pp. 4944-4948 (1985).
Tanese, N., et al., J. Virology, vol. 59, pp. 743-745 (1986).
Tanese, N. and Goff, S. P., Proc. Natl. Acad. Sci. USA, vol. 85, pp. 1777-1781 (1988).
Tanese, N., et al., DNA, vol. 7, pp. 407-416 (1988).
Wain-Hobson, S., et al., Cell, vol. 40, pp. 9-17 (1985).

Affiliated with

Also associated with

Rating

Expression of human immunodeficiency virus (HIV) reverse transcr does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Expression of human immunodeficiency virus (HIV) reverse transcr, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Expression of human immunodeficiency virus (HIV) reverse transcr will most certainly appreciate the feedback.

Rate now

Comments { 0 }

Profile ID: LFUS-PAI-O-1154905